Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
September 30, 2026 0.614M
June 30, 2026 0.695M
March 31, 2026 4.716M
December 31, 2025 6.954M
September 30, 2025 7.743M
June 30, 2025 0.034M
March 31, 2025 0.032M
December 31, 2024 0.159M
September 30, 2024 0.08M
June 30, 2024 0.028M
March 31, 2024 0.03M
December 31, 2023 0.026M
September 30, 2023 0.025M
June 30, 2023 -0.026M
March 31, 2023 0.056M
December 31, 2022 0.061M
September 30, 2022 0.048M
June 30, 2022 0.057M
March 31, 2022 0.054M
December 31, 2021 0.0117M
September 30, 2021 0.1337M
June 30, 2021 0.1201M
March 31, 2021 0.2819M
December 31, 2020 0.0357M
September 30, 2020 0.0726M
Date Value
June 30, 2020 17.22M
March 31, 2020 0.0084M
December 31, 2019 0.4602M
September 30, 2019 23.59M
June 30, 2019 -0.05M
March 31, 2019 0.0315M
December 31, 2018 0.0125M
September 30, 2018 0.0159M
June 30, 2018 -0.0653M
March 31, 2018 9.959M
December 31, 2017 -0.0885M
September 30, 2017 0.1107M
June 30, 2017 0.0095M
March 31, 2017 -0.0907M
December 31, 2016 -0.2015M
September 30, 2016 7.209M
June 30, 2016 2.897M
March 31, 2016 -0.0234M
December 31, 2015 0.3562M
September 30, 2015 0.0334M
June 30, 2015 0.1059M
March 31, 2015 0.5093M
December 31, 2014 -0.0786M
September 30, 2014 0.4719M
June 30, 2014 2.413M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Electromed, Inc. -4.746M
CVRx, Inc. 5.155M
Accuray, Inc. 11.16M
Orthofix Medical, Inc. -3.549M
ResMed, Inc. -1.278B